Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-25 @ 4:07 AM
NCT ID:
NCT04222920
Eligibility Criteria:
Inclusion Criteria:
* Rheumatoid arthritis patient, according to ACR 1987 or ACR/EULAR 2010
* Treated for at least 28 weeks with adalimumab
* Adalimumab trough concentration \>5mg/L
* Who has agreed to participate (written informed consent);
* Age 18 years or older.
Exclusion Criteria:
* scheduled surgery during the follow-up of the study or other pre-planned reasons for treatment discontinuation
* life expectancy shorter than follow-up period of the study;
* other disease that might flare if adalimumab is tapered like psoriasis, inflammatory bowel disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04222920
Study Brief:
Protocol Section:
NCT04222920